BATF2
Appearance
| BATF2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Identifiers | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Aliases | BATF2, SARI, basic leucine zipper ATF-like transcription factor 2 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| External IDs | OMIM: 614983; MGI: 1921731; GeneCards: BATF2 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Wikidata | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Basic leucine zipper transcription factor, ATF-like 2 is a protein that, in humans, is encoded by the BATF2 gene.[5]
References
[edit]- 1 2 3 GRCh38: Ensembl release 89: ENSG00000168062 – Ensembl, May 2017
- 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000039699 – Ensembl, May 2017
- ↑ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ↑ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ↑ "Entrez Gene: Basic leucine zipper transcription factor, ATF-like 2". Retrieved 2014-07-06.
Further reading
[edit]- Ma H, Liang X, Chen Y, Pan K, Sun J, Wang H, et al. (February 2011). "Decreased expression of BATF2 is associated with a poor prognosis in hepatocellular carcinoma". International Journal of Cancer. 128 (4): 771–777. doi:10.1002/ijc.25407. PMID 20473897.
- Dash R, Su ZZ, Lee SG, Azab B, Boukerche H, Sarkar D, et al. (August 2010). "Inhibition of AP-1 by SARI negatively regulates transformation progression mediated by CCN1". Oncogene. 29 (31): 4412–4423. doi:10.1038/onc.2010.194. PMID 20531301.
- Huang Q, Li XQ, Yang Y, Huang SA (August 2011). "[Influence of BCR-ABL inhibitor STI571 on SARI expression in K562 cells]". Zhongguo Shi Yan Xue Ye Xue Za Zhi. 19 (4): 865–868. PMID 21867603.
- Su ZZ, Lee SG, Emdad L, Lebdeva IV, Gupta P, Valerie K, et al. (December 2008). "Cloning and characterization of SARI (suppressor of AP-1, regulated by IFN)". Proceedings of the National Academy of Sciences of the United States of America. 105 (52): 20906–20911. Bibcode:2008PNAS..10520906S. doi:10.1073/pnas.0807975106. PMC 2634918. PMID 19074269.
- Wang C, Su Y, Zhang L, Wang M, You J, Zhao X, et al. (2012). "The function of SARI in modulating epithelial-mesenchymal transition and lung adenocarcinoma metastasis". PLOS ONE. 7 (9) e38046. Bibcode:2012PLoSO...738046W. doi:10.1371/journal.pone.0038046. PMC 3458851. PMID 23049725.
- Wenig JA (May 1990). "Os trigonum syndrome". Journal of the American Podiatric Medical Association. 80 (5): 278–282. doi:10.7547/87507315-80-5-278. PMID 2366175.
- Huang Q, Yang Y, Li X, Huang S (December 2011). "Transcription suppression of SARI (suppressor of AP-1, regulated by IFN) by BCR-ABL in human leukemia cells". Tumour Biology. 32 (6): 1191–1197. doi:10.1007/s13277-011-0222-1. PMID 21892628. S2CID 21309704.